The Africa Oxford Initiative is hosting the next insaka on December 6 2019 at St Cross College. Speakers include Professor Helen Fletcher, UK Research and Innovation and Professor Alain Stein, Department of Psychiatry. The talks will be followed by a drinks reception. To register for free, see link above.
Professor Sir Peter Ratcliffe will be giving the Haldane Lecture on Thursday 21 November at 4 pm in the Large Lecture Theatre, Sherrington Building, DPAG. Further details can be found at: https://new.talks.ox.ac.uk/talks/id/0a583c95-d492-415d-b395-80c104199b54/ All welcome!
Identifying target proteins for the selection of new drugs
Professor Chas Bountra is interested in identifying and validating target proteins for drug discovery. Various technologies and strategies have allowed him to progress promising clinical candidates into Phase I, II, III studies, and to market. These new drugs offer novel treatments for neurodegenerative and gastrointestinal diseases, as well as pain disorders.
Rachel Tanner, from the Jenner Institute, has been awarded the 2019 'Woman of the Future award for Science' Prof Helen McShane says: "Rachel is an outstanding scientist. Her work has centred around the development, optimisation and establishment of a functional in vitro mycobacterial growth inhibition assay for TB vaccine evaluation. She has led work programmes funded by the European Commission to transfer this assay to other laboratories and in doing so has established herself as a committed, highly effective and successful scientist. I am delighted that her trajectory and progress has been recognised by this prestigious award"
New research from the Big Data Institute, in collaboration with the George Institute has revealed that the health implications of obesity extend much further than diabetes and heart disease, increasing the risk of death from diseases of the kidneys, lungs and liver. The study found that obese individuals are more likely to be affected by chronic obstructive pulmonary disease, chronic kidney disease, liver diseases and lung cancer - life-threatening conditions that the World Health Organization has ranked as leading causes of death and disability.
United Nations sustainable development goals aim for the elimination of viral hepatitis as a public health threat by 2030, leading to efforts to upscale the availability and accessibility of hepatitis B virus (HBV) vaccination, diagnosis, and treatment globally. However, a variety of societal factors, including beliefs, traditions, and stigma, can be a major obstacle to all of these interventions. Philippa Matthews and co-researchers set out to investigate how HBV is understood and described in communities in Uganda, and whether there is evidence of potential stigma.
© 2019 Offices of the Nuffield Professor of Medicine, Nuffield Department of Medicine, University of Oxford
Henry Wellcome Building for Molecular Physiology, Old Road Campus, Headington, Oxford OX3 7BN
Driven by 
Newt, Powered by 
Pinfox
Home
| Site Map
| Contact
| Freedom of Information
| Privacy Policy
| Copyright
| Accessibility
Medical Sciences Division
| Oxford University
